Expression of A, G and B melanoma antigen genes in human hepatocellular carcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 1, Issue 4, 2002, Pages 570-573

  Chen, Zhi ^a   Shao, Jun Bing ^a   Wu, Wei ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

A melanoma antigen; B melanoma antigen; G melanoma antigen; Hepatocellular carcinoma

Indexed keywords

MELANOMA ANTIGEN; MESSENGER RNA; MOLECULAR MARKER; TUMOR ANTIGEN;

ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, NEOPLASM; BIOPSY; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION; HUMANS; LIVER; LIVER NEOPLASMS; MELANOMA; RNA, MESSENGER;

EID: 0038205650     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Kobayashi Y, Higashi T, Nouso K, et al. Expression of MAGE, GAGE and BAGE genes in human liver diseases: utility as molecular markers for hepatocellular carcinoma. J Hepatol 2000;32:612-617.
2. Castelli C, Rivoltini L, Andreola G, et al. T-cell recognition of melanoma-associated antigens. J Cell Physiol. 2000;182:323-331.
3. Li J, Yang Y, Fujie T, et al. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. Clin Cancer Res 1996;2:1619-1625.
4. Okuda K. Hepatocelluar carcinoma: recent progress. Hepatology 1992;15:948-963.
5. Gaugler B, van den Eynde B, van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994;179:921-930.
6. Van den Eynde B, Peeters O, De Backer O, et al. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995;182:689-698.
7. Boel P, Wildmann C, Sensi ML, et al. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995;2:167-175.
8. Zeuthen J, Dzhandzhugazyan K, Hansen MR, et al. The immunogenic properties of human melanomas and melanoma-associated antigens recognized by cytotoxic T lymphocytes. Bratisl Lek Listy 1998;99:426-434.
9. Durrant LG. Cancer vaccines. Anticancer Drugs 1997;8:727-733.
10. Dalerba P, Ricci A, Russo V, et al. High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: implications for protocol design of therapeutic antigen-specific vaccination strategies. Int J Cancer 1998; 77: 200-204.